Principal Financial Group Inc Adamis Pharmaceuticals Corp Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.34 - $0.57 $5,736 - $9,617	-16,872 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.55 - $0.73 $522 - $693	-950 Reduced 5.33%	16,872 $10,000
Q4 2021 Feb 09, 2022	SELL	$0.57 - $1.23 $5,725 - $12,354	-10,044 Reduced 36.04%	17,822 $11,000
Q3 2021 Nov 09, 2021	SELL	$0.92 - $1.18 $4,156 - $5,331	-4,518 Reduced 13.95%	27,866 $27,000
Q2 2021 Aug 10, 2021	BUY	$0.66 - $1.23 $21,373 - $39,832	32,384 New	32,384 $35,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.